Search Results
Oct 10, 2025, 08:00 ET FREDERICK COUNTY CHAMBER OF COMMERCE ANNOUNCES NEW BOARD OF DIRECTORS
FREDERICK, Md., Oct. 10, 2025 /PRNewswire/ -- The Frederick County Chamber of Commerce is pleased to announce the members of the Board of Directors for 2025-2026. Danny
More news about: Frederick County Chamber of Commerce
Oct 10, 2025, 08:00 ET Mount St. Mary's University serves more than 160 meals at Emmitsburg Neighborhood Meal
volunteers prepared and served over 160 meals. EMMITSBURG, Md., Oct. 10, 2025 /PRNewswire/ -- Mount St. Mary's University students, faculty, and staff joined forces with the
More news about: Mount St. Mary's University
Oct 10, 2025, 08:00 ET Sass Magazine Celebrates Release of 2025 LOCAL Issue
FREDERICK, Md., Oct. 10, 2025 /PRNewswire/ -- Sass Magazine is proud to announce the launch of its Sept/Oct 2025 LOCAL Issue, a vibrant celebration of Frederick County's people, places, and
More news about: Sass Magazine
Oct 10, 2025, 07:48 ET Alamar Biosciences lanza el ensayo NULISAqpcr™ BD-pTau217 para la investigación de la enfermedad de Alzheimer
precisión". "El rendimiento de los ensayos de pTau217 plasmáticos específicos del cerebro de Alamar es excelente", afirmó Jonathan Schott, MD, PhD, profesor de Neurología del University College de Londres. "Para la detección de la patología de Alzheimer con síntomas cognitivos, nuestros primeros
More news about: Alamar Biosciences, Inc.
Oct 10, 2025, 02:00 ET Renalys Announces Completion of Primary Endpoint Data Collection for Phase III Clinical Trial of Sparsentan for Iga Nephropathy in Japan
Company Name: Renalys Pharma, Inc.Address: 3-11, Nihonbashi-honcho 2-chome, Chuo-ku, Tokyo, JapanRepresentative: BT Slingsby, MD, PhD, MPHEstablished: April 2023URL: https://renalys.com/
More news about: Renalys Pharma, Inc.
Oct 09, 2025, 21:38 ET Dr. Sanusi Umar lanza The Bumpinator, una serie de documentos digitales que aborda afecciones complejas de la piel y el cabello que otros no podrían
mismo: restaurar la confianza a través del conocimiento y la innovación". Acerca del Dr. Sanusi UmarDr. Sanusi Umar, MD, FAAD, es dermatóloga certificada por la junta, cirujana de restauración capilar, inventora y educadora. Dirige la Clínica del Cabello y la Piel del Dr.
More news about: Dr. U Hair and Skin Clinic
Oct 09, 2025, 18:15 ET Lockheed Martin Declares Fourth Quarter 2025 Dividend
BETHESDA, Md., Oct. 9, 2025 /PRNewswire/ -- The Lockheed Martin Corporation (NYSE: LMT) board of directors has authorized a fourth quarter 2025 dividend of $3.45 per share. This is an increase
More news about: Lockheed Martin
Oct 09, 2025, 17:16 ET Amplifi Vascular Announces Successful First-in-Human Study Results, Closes $6.8M Series A, and Receives FDA IDE Approval
AMPLIFI-1, a U.S. clinical investigation evaluating safety, performance, and time to functional maturation compared with standard care. Surendra Shenoy, MD, Washington University, St. Louis School of Medicine said, "Early outcomes suggest that proactive vein dilation prior to AVF surgery can significantly
More news about: Amplifi Vascular, Inc
Oct 09, 2025, 17:14 ET Alamar Biosciences Launches NULISAqpcr™ BD-pTau217 Assay: A Breakthrough in Non-Invasive, Brain-Specific Biomarker Detection for Alzheimer's Disease Research
with higher precision." "The performance of Alamar's brain-specific plasma pTau217 assays is excellent," said Jonathan Schott, MD, PhD, Professor of Neurology, University College London. "For the detection of Alzheimer's pathology with cognitive symptoms, our early results suggest
More news about: Alamar Biosciences, Inc.
Oct 09, 2025, 16:54 ET Alamar Biosciences Launches NULISAqpcr™ BD-pTau217 Assay: A Breakthrough in Non-Invasive, Brain-Specific Biomarker Detection for Alzheimer's Disease Research
with higher precision." "The performance of Alamar's brain-specific plasma pTau217 assays is excellent," said Jonathan Schott, MD, PhD, Professor of Neurology, University College London. "For the detection of Alzheimer's pathology with cognitive symptoms, our early results suggest
More news about: Alamar Biosciences, Inc.